Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:06 PM
Ignite Modification Date: 2025-12-25 @ 4:40 PM
NCT ID: NCT03300557
Description: None
Frequency Threshold: 2
Time Frame: 3 months
Study: NCT03300557
Study Brief: Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Treatment (Exemestane) Patients receive exemestane PO QD over 21-42 days in the absence of disease progression or unaccepted toxicity. Patients undergo standard of care surgery between days 22-43. Exemestane: Given PO Laboratory Biomarker Analysis: Correlative studies Pharmacokinetic Study: Correlative studies Questionnaire Administration: Ancillary studies 0 None 0 40 38 40 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hot flashes SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v4.0 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v4.0 View
Flushing SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v4.0 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Bloating SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Stomach pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Blurred vision SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v4.0 View
Eye disorders - Other, specify SYSTEMATIC_ASSESSMENT Eye disorders CTCAE v4.0 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Arthritis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Chest wall pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Musculoskeletal and connective tissue disorder - Other, specify SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v4.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v4.0 View
Concentration impairment SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v4.0 View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v4.0 View
Paresthesia SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v4.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Edema limbs SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Chills SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Fever SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Flu like symptoms SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v4.0 View
Hyperhidrosis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v4.0 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v4.0 View
Skin and subcutaneous tissue disorders - Other, specify SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v4.0 View
Allergic rhinitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v4.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v4.0 View
Nasal congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v4.0 View
Sneezing SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v4.0 View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v4.0 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE v4.0 View
Alanine aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations CTCAE v4.0 View
Blood bilirubin increased SYSTEMATIC_ASSESSMENT Investigations CTCAE v4.0 View
Urinary frequency SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v4.0 View
Urinary urgency SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v4.0 View
Urine discoloration SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE v4.0 View